Holen Sie sich die Stockscreener-App
0.5704
4.09%
-0.0243
Handel nachbörslich:
.61
0.0396
+6.94%
Schlusskurs vom Vortag:
$0.5947
Offen:
$0.602
24-Stunden-Volumen:
655.18K
Relative Volume:
1.83
Marktkapitalisierung:
$83.27M
Einnahmen:
$49.09M
Nettoeinkommen (Verlust:
$-52.15M
KGV:
-0.8775
EPS:
-0.65
Netto-Cashflow:
$-45.93M
1W Leistung:
-14.87%
1M Leistung:
-20.78%
6M Leistung:
-66.25%
1J Leistung:
-62.23%
1-Tages-Spanne:
$0.5416
$0.619
1-Wochen-Bereich:
$0.5416
$0.7488
52-Wochen-Spanne:
$0.5416
$2.04
Biodesix Inc Stock (BDSX) Company Profile
Firmenname
Biodesix Inc
Sektor
Branche
Telefon
303-417-0500
Adresse
919 WEST DILLON ROAD, LOUISVILLE
Vergleichen Sie BDSX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BDSX
Biodesix Inc
|
0.5704 | 83.27M | 49.09M | -52.15M | -45.93M | -0.65 |
|
TMO
Thermo Fisher Scientific Inc
|
437.91 | 165.21B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
181.77 | 130.05B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
393.73 | 31.91B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
103.00 | 29.38B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
154.73 | 27.28B | 15.41B | 1.37B | 2.11B | 7.50 |
Biodesix Inc Stock (BDSX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-07-26 | Eingeleitet | Craig Hallum | Buy |
| 2024-05-13 | Eingeleitet | TD Cowen | Buy |
| 2024-05-03 | Eingeleitet | Lake Street | Buy |
| 2021-11-17 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-23 | Eingeleitet | BTIG Research | Buy |
| 2020-11-23 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-11-23 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-11-23 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Biodesix Inc Aktie (BDSX) Neueste Nachrichten
Biodesix, Inc. (NASDAQ:BDSX) Short Interest Update - MarketBeat
HighTower Advisors LLC Acquires 22,500 Shares of Biodesix, Inc. (NASDAQ:BDSX) - Defense World
AIGH Capital Management LLC Buys 500,000 Shares of Biodesix, Inc. (NASDAQ:BDSX) - MarketBeat
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Perkins Capital Management Inc. Purchases 335,429 Shares of Biodesix, Inc. (NASDAQ:BDSX) - MarketBeat
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Biodesix Completes Enrollment of INSIGHT Study Assessing Clinical Utility of the VeriStrat® Blood-Based Host Immune Classifier - Business Wire
Biodesix, Inc. (NASDAQ:BDSX) Short Interest Up 24.6% in February - Defense World
Biodesix to Present at Cowen’s 42nd Annual Healthcare Conference - Business Wire
Biodesix chief commercial officer sells shares worth $16,198 - MSN
Q1 Earnings Estimate for Biodesix Issued By William Blair - MarketBeat
Biodesix's (BDSX) "Outperform" Rating Reaffirmed at William Blair - MarketBeat
Biodesix (NASDAQ:BDSX) Issues Quarterly Earnings Results - MarketBeat
Q1 Earnings Forecast for Biodesix Issued By William Blair - Defense World
Biodesix (BDSX) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Biodesix improved sales, cut losses in fourth quarter, fiscal 2024 - BizWest
Biodesix at TD Cowen Conference: Transformative Year Ahead By Investing.com - Investing.com UK
Biodesix at TD Cowen Conference: Transformative Year Ahead - Investing.com
Analysts Have Been Trimming Their Biodesix, Inc. (NASDAQ:BDSX) Price Target After Its Latest Report - Yahoo Finance
William Blair Estimates Biodesix’s Q1 Earnings (NASDAQ:BDSX) - Defense World
It's Down 30% But Biodesix, Inc. (NASDAQ:BDSX) Could Be Riskier Than It Looks - Simply Wall St
Biodesix (NASDAQ:BDSX) Receives “Outperform” Rating from William Blair - Defense World
Biodesix, Inc. Reports Strong Growth Amid Financial Challenges - TipRanks
Positive Outlook for Biodesix: Buy Rating Supported by Salesforce Improvements and Revenue Growth Opportunities - TipRanks
Earnings call transcript: Biodesix Q4 2024 beats revenue expectations By Investing.com - Investing.com South Africa
Observations on the Biodesix Inc (NASDAQ:BDSX) Growth Curve - US Post News
Biodesix, Inc. (NASDAQ:BDSX) Q4 2024 Earnings Call Transcript - MSN
Biodesix: Strong Growth and Promising Future with Buy Rating from Kyle Mikson CFA - TipRanks
US Futures Tumble As Traders Await Trump's Congress Address: 'Volatility Is Certainly Being Fed By Trump 2.0 Moves,' Says ExpertCrowdStrike Holdings (NASDAQ:CRWD), Biodesix (NASDAQ:BDSX) - Benzinga
Biodesix, Inc. (BDSX): Among Penny Stocks with Insider Buying in 2025 - Insider Monkey
12 Penny Stocks with Insider Buying in 2025 - Insider Monkey
Biodesix Inc (BDSX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Biodesix Inc (BDSX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Biodesix Reports Strong 2024 Financial Performance - TipRanks
Biodesix Inc reports results for the quarter ended December 31Earnings Summary - TradingView
BIODESIX Earnings Results: $BDSX Reports Quarterly Earnings - Nasdaq
Earnings call transcript: Biodesix Q4 2024 beats revenue expectations - Investing.com
Biodesix earnings beat by $0.01, revenue topped estimates - Investing.com Canada
Earnings Flash (BDSX) BIODESIX INC. Reports Q4 Revenue $20.4M, vs. FactSet Est of $19.9M - Marketscreener.com
Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results - GlobeNewswire
Biodesix chief accounting officer Chris Vazquez sells $3,354 in stock - MSN
Biodesix (BDSX) Expected to Announce Quarterly Earnings on Monday - Defense World
Biodesix Inc expected to post a loss of 7 cents a shareEarnings Preview - TradingView
Finanzdaten der Biodesix Inc-Aktie (BDSX)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):